Bioactivity:

Dehydroglyasperin D exhibits anticancer, anti-inflammatory, anti-obesity, antioxidant and anti-aldose reductase effects, it inhibits the proliferation of HT-29 human colorectal cancer cells through direct interaction with phosphatidylinositol 3-kinase; it

CAS nr:

517885-72-2

Purity:

98%

Molecular Weight:

368,42

SMILES:

COc1cc2OCC(=Cc2c(OC)c1CC=C(C)C)c1ccc(O)cc1O

Formula:

C22H24O5

Pathway:

DNA Damage/DNA Repair,PI3K/Akt/mTOR signaling,Immunology/Inflammation,Immunology/Inflammation,MAPK,GPCR/G Protein,Stem Cells,PI3K/Akt/mTOR signaling,Immunology/Inflammation,MAPK,Cytoskeletal Signaling,PI3K/Akt/mTOR signaling,Cell Cycle/Checkpoint,Neuroscience

Target:

DNA/RNA Synthesis,PI3K,ROS,Prostaglandin Receptor,JNK,Prostaglandin Receptor,GSK-3,GSK-3,COX,p38 MAPK,Akt,Akt,DNA/RNA Synthesis,COX